Technology-Based Application To Improve The Triple Therapy Adherence Rate In Subjects With Hepatitis C Infection
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02070107|
Recruitment Status : Withdrawn (Sponsored withdrew)
First Posted : February 24, 2014
Last Update Posted : August 7, 2017
University of Louisville
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Matthew Cave, University of Louisville
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Recruitment Status :||Withdrawn|
|Actual Primary Completion Date :||March 2016|
|Actual Study Completion Date :||March 2016|